Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWa...( BOSTON Feb. 6 /- CenterWatch a pu...),Health

BOSTON, Feb. 6 /PRNewswire/ -- CenterWatch, a publishing and information services company focused on market research about clinical trials, finds in a new report that the Asia-Pacific region is grabbing an increasing share of the global clinical trial market, and with new regulatory changes across the region, has already been growing at more than 50% in recent years.

According to the new 160-plus page report from CenterWatch entitled, Asia- Pacific's Growing Role in Global Clinical Trials, Asia Pacific countries are tapping into their power as a bloc to boost their role in the expanding global clinical trials market.

An important part of the report contains the results from CenterWatch's first-ever survey of clinical researchers in the region. CenterWatch surveyed more than 156 investigative sites from more than a dozen countries in Asia Pacific. The survey revealed, among other results, the key role of electronic data capture (EDC) of clinical trial information in this region.
Highlights of this report include:

* Charts of survey results from CenterWatch's ground-breaking investigator

survey of the region. Fifty charts with proprietary data are included.

* A pipeline of drugs in development in Asia-Pacific countries.

* Extensive interviews with executives from global pharmaceutical

companies and contract research organizations (CRO) who have on-the-

ground experience in the Asia-Pacific region.

* A breakdown of contract research organizations country-by-country.

The global CRO market has been a great worldwide growth story and the Asia-Pacific region has been one of the hottest areas for this growth. 2007 saw more CRO mergers and acquisitions--35--than in any previous year since CenterWatch began tracking the market in the mid 1990s when contract research took off.

"More than half of those acquisitions were made to take advantage of the growth in global clinical trials
'/>"/>